EAN News

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for April 2023.

We are proud to announce a new education initiative: the EAN Regional Teaching Session, bringing EAN-organised sessions to your national meeting.

Join our team of leading experts, policymakers and stakeholders on a journey through the European brain health landscape on May 9.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for March 2023.

MSIF’s application to add Multiple Sclerosis treatments to the WHO Essential Medicines List has the potential to put MS higher on the agenda of the WHO and individual countries.

EAN Education Committee Chair, Irena Rektorová, gives an update on new projects, upcoming deadlines, and some exciting additions to existing educational programmes.

Our paper of the month presents the results of a prospective, double-blind, randomised, sham-controlled trial involving 16 centres and investigating the safety and efficacy of unilateral FUSA of the globus pallidus internus in patients with medication-refractory idiopathic PD.

Are you a neurologist whose line of work was affected by the pandemic? We want to hear how COVID-19 has impacted your professional field.

The European Academy of Neurology is proud to announce the launch of the EAN CoCoCare, its very own guideline educational programme for 2023!

President of the Turkish Neurological Society, shares a statement on the tragic aftermath of the earthquake in Türkiye and Syria and honours the memory of the neurologists lost.

EAN President, Paul Boon, provides an update on some upcoming major EAN events (including EAN 2023) and freshly launched EAN projects.

Our February Paper of the Month is a narrative review focusing on epidemiology, pathophysiology and treatment of secondary headache following SARS-COV-2 infection and vaccination, and on the impact of COVID-19 pandemic on primary headache disorders.

Our paper of the month is a retrospective nationwide cohort study that was carried out to determine the clinical sequelae of long covid for a year after infection in patients with mild disease, and to evaluate its association with age, sex, SARS-CoV-2 variants, and vaccination status.

We are very happy to announce the launch of the new EAN Leadership Programme, to teach essential leadership and advocacy skills that are not commonly learned at medical school or in daily practice.

Our highlighted selection of Covid-related Literature Reviews from the scientific press for January 2023.